CClinicalTrials.gg
CompletedNCT04104555OSTRICHUpdated Nov 29, 2023

Orthotics for Treatment of Symptomatic Flat Feet in Children

An interventional study of Birthday card and Prefabricated orthoses in Pes Planus, sponsored by University of York. Completed at 16 sites in United Kingdom. Open to participants aged 6 Years to 14 Years. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by University of York · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Randomized
Ages
6 Years to 14 Years
Sex
All
01

Study summary

Update 13.12.2021 To mitigate the effects the COVID-19 pandemic, and due to difficulties in sites setting up the custom orthoses arm of the protocol an amendment was approved to change the design of the study from a 3 to a 2 arm trial. The amendment drops the custom orthoses arm and was implemented prior to the start of recruitment.

As a child grows the shape of their foot changes and most develop an arch in their foot. For some, however, the arch does not fully form or it might be flat against the ground. This is known as having flat feet and it can cause pain in the feet, legs, or back. At the moment, we are not sure what the best treatment for flat feet is, so the purpose of this research is to conduct a trial to compare two of the most common treatments. The first is exercise and advice about things like which types of shoes might help. The second of the treatment is a type of insole, which is put inside the shoe.

Participants will receive their treatment as part of their normal National Health System care. We would like 478 children and young people aged between 6 and 14 years old to take part in the study. Everyone will receive advice about the type of shoes to wear, ankle exercises and things to look out for when children have painful flat feet. In addition to this, half of the participants will receive a pre-made insole that is the right size. We will ask for their help for 12 months. During this time, we will track their progress by sending them 3 questionnaires in the post to fill in and weekly text messages to find out how painful their feet are during the first few months. We also want to learn more about the problems that flat feet cause, and children's experiences of the treatments delivered as part of this clinical trial. We will explore this through in-depth conversations with children and their parent(s) or the person who looks after them. Once we have finished the trial, we will work with the people who took part in the trial, and clinicians, to make sure that our results can be used by as many people as possible.

We will run 3 additional studies. The first will find out if having information about the study in the form of a video in addition to information in a paper booklet will increase recruitment rates. The second will find out if sending participants a birthday card will increase the response rates to postal questionnaires. The third study will take a 3D impression of the participant's foot and see if it changes over the course of the study.

Read the detailed description

The aim of the study is to undertake a large, pragmatic, multi-armed, randomised controlled trial to assess the clinical and cost-effectiveness of prefabricated orthoses in addition to exercises and advice compared with exercises and advice alone on the physical functioning of children with symptomatic flat feet. We will aim to recruit 478 children with flat feet. They will be allocated to one of two groups, in a 1:1 ratio to either (a) prefabricated orthoses plus exercises and footwear advice or (b) exercises and footwear advice only. We will follow the participants up for 12 months after randomisation to assess their physical functioning, levels of pain and quality of life. We will undertake qualitative interviews with approximately 30 children and their parents, to find out about their experiences of having flat feet, and of being in the trial.

In addition to the main OSTRICH study we will undertake two additional trial methodological Studies within a Trial (SWAT) and a sub-study.

The multimedia trial information SWAT: This SWAT will evaluate the effectiveness of including signposting to multimedia trial information in the patient information sheet, which is sent to participants in their recruitment pack.

The birthday card SWAT: This SWAT will evaluate the effectiveness of sending a birthday card to participants on response rates to postal questionnaires.

Foot scan sub-study: This embedded observational sub-study will assess the capability of a 3D scanning approach to identify and stratify severity of pes planus and to assess change in foot shape over the duration of the trial. We will investigate the associations between aspects of foot shape and score on the physical domain scale of the OxAFQ-C.

02

Conditions studied

  • Pes Planus

Browse trials for

Keywords

  • Pes planus
  • Randomised controlled trial
  • Orthoses
  • Exercise
  • Children
03

In context

Flatfoot

168 studies on the registry are indexed under Flatfoot; 41 are open to participants now.

This study's enrollment of 134 is above the median of 37 across 121 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

University of York is the lead sponsor of 11 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

OSTRICH main trial inclusion criteria:

Potential participants will be included in the trial if they fulfil all of the following criteria:

  • Are aged between six and 14 years, inclusive
  • Have one or both symptomatic pes planus*
  • The child and/or parent/legal guardian is able to speak, write and understand English
  • The parent/legal guardian is able to give informed consent *Symptomatic pes planus is described as the manifestation of foot and lower limb symptoms, secondary to altered foot alignment (reduced medial longitudinal arch, everted rearfoot and abducted forefoot). The diagnosis will be made pragmatically, by treating clinicians in line with current practice

OSTRICH main trial exclusion criteria:

Potential participants will be excluded from the study if they fulfil any of the following criteria:

  • Have a history of major trauma or fracture of the lower leg (below knee)
  • Have pes planus secondary to any systematic condition/syndrome** /malignancy
  • Have a history of foot and/or ankle surgery
  • Require an ankle-foot orthoses or other lower limb device or have received treatment previously for their flat feet

    • This does not exclude children with hypermobility spectrum disorder (HSD) where the manifestation is non-syndromic and isolated (L-HSD), peripheral (P-HSD) or generalised hypermobility (G-HSD)(14).

OSTRICH signposting to multimedia trial information SWAT: inclusion criteria any potential participant identified as eligible to be sent trial information from a site taking part in the SWAT, will be eligible for the study.

OSTRICH birthday card SWAT Inclusion criteria: All participants recruited into the host trial will be eligible to take part in this SWAT. Exclusion criteria: Any participant who has withdrawn from the main OSTRICH study or is not due a follow up questionnaire will be excluded.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
134 participants (actual)

Study arms

  • Active comparator
    Usual supportive care - exercises and footwear advice

    OSTRICH main trial: Participants will be offered an exercise programme and advice regarding footwear. The treating clinician will be able to prescribe appropriate exercises from a menu of exercises.

    Other: Usual supportive care - exercises and footwear advice (the comparator)

  • Experimental
    Prefabricated, off-the-shelf orthoses

    OSTRICH main trial: A pair of prefabricated, off-the-shelf orthoses (i.e. mass produced to a generic shape but can be adapted by a clinician) plus an exercise programme and advice regarding footwear. The treating clinician will be able to prescribe appropriate exercises from a menu of exercises.

    Device: Prefabricated orthoses

  • Experimental
    Signposting to multimedia

    OSTRICH 'signposting to multimedia' Study within a trial (SWAT) Participants will be given signposting information to the multimedia trial information resources in the participant information sheet which is included in the OSTRICH recruitment pack.

    Other: Signposting to multimedia

  • No intervention
    Standard written information only

    OSTRICH signposting to multimedia' Study within a trial (SWAT) Participants will receive the standard written information sheet only. This will not include signposting to the multimedia trial information resources, in the OSTRICH recruitment pack.

  • Experimental
    Birthday card

    OSTRICH Birthday card study within a trial (SWAT) Participants will be sent a birthday card on or shortly before their birthday from the OSTRICH study team to encourage completion of questionnaires.

    Other: Birthday card

  • No intervention
    No birthday card

    OSTRICH Birthday card study within a trial (SWAT) Participants will not be sent a birthday card during the trial.

Interventions

  • OtherBirthday card

    Birthday card sent to participants in the post

  • DevicePrefabricated orthoses

    Prefabricated insole

  • OtherSignposting to multimedia

    Signposting to multimedia information in the patient information sheet which is sent to participants in the post as part of the OSTRICH recruitment pack.

  • OtherUsual supportive care - exercises and footwear advice (the comparator)

    Active comparator

06

What researchers measure

Primary outcomes

  1. Physical domain subscale of the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C) over the 12 month follow-up period.

    The OxAFQ-C is a self-report health status measure questionnaire for child patients (aged 5-14) affected by foot and ankle conditions that are considered important to children. There are three domains, whose domain scores are reported separately (ie there is no total score). For the primary outcome however, we will just use the physical domain subscale. There are 6 items on the 'Physical' domain. The response options to each item are on a 5-point scale rated from never (4), rarely (3), sometimes (2), very often (1) to always (0), where the number in brackets represents the value that should be applied to each response. The total 'physical domain score' is divided by the maximum for the domain ie 24. This score can then be transformed to a percentage scale (0-100) to aid interpretation. A higher score for a domain represents better functioning. This will be rated by the child (participant) and their parent/legal guardian using a proxy version.

    Time frame: For the primary comparison the physical domain subscale will be compared between the groups using a linear covariance pattern mixed model to estimate the effect over the whole 12 month followup, incorporating data from all available time points

Secondary outcomes

  1. The 'School and Play' domain of the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C)

    The OxAFQ-C is a self-report health status measure questionnaire for child patients (aged 5-14) affected by foot and ankle conditions that are considered important to children. There are three domains, whose domain scores are reported separately (ie there is no total score). However for the secondary outcome we will use the 'School and Play' domain. There are 4 items on the 'School and Play' domain. The response options to each item are on a 5-point scale rated from never (4), rarely (3), sometimes (2), very often (1) to always (0), where the number in brackets represents the value that should be applied to each response. The total of the 'School and Play' domain score is divided by the maximum for the domain ie 16. This score can then be transformed to a percentage scale (0-100) to aid interpretation. A higher score for a domain represents better functioning. This will be rated by the child (participant) and their parent/legal guardian using a proxy version.

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

  2. The 'Emotional' subscale of the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C)

    The OxAFQ-C is a self-report health status measure questionnaire for child patients (aged 5-14) affected by foot and ankle conditions that are considered important to children. There are three domains, whose domain scores are reported separately (ie there is no total score). However for the secondary outcome we will use the 'Emotional' domain. There are 4 items on the 'Emotional' domain. The response options to each item are on a 5-point scale rated from never (4), rarely (3), sometimes (2), very often (1) to always (0), where the number in brackets represents the value that should be applied to each response. The total of the 'Emotional' domain score is divided by the maximum for the domain score ie 16. This score can then be transformed to a percentage scale (0-100) to aid interpretation. A higher score for a domain represents better functioning. This will be rated by the child (participant) and their parent/legal guardian using a proxy version.

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

  3. Footwear item of the Oxford Ankle Foot Questionnaire for Children (OxAFQ-C)

    The OxAFQ-C is a self-report health status measure questionnaire for child patients (aged 5-14) affected by foot and ankle conditions that are considered important to children. This item was added to reflect the concern by many children that they can or cannot wear the footwear they prefer. It is a 5-point scale rated from never (4), rarely (3), sometimes (2), very often (1) to always (0), where the number in brackets represents the value. It is reported as a single item with higher score representing better functioning. This will be rated by the child (participant) and their parent/legal guardian using a proxy version.

    Time frame: Collected at baseline, 3, 6 and 12 months post randomisation

  4. EuroQoL-Five Dimension Youth

    The EuroQoL-5 Dimension Youth (EQ5DY) is a child friendly, generic quality of life measure. Health status is measured in terms of 5 domains: "mobility", "looking after myself", "doing usual activities", "having pain or discomfort" and "feeling worried, sad or unhappy". Each dimension has 3 levels ranging from 1 no problems, 2 some problems and 3 a lot of problems. The respondent is asked to indicate their health state by ticking in the box against the most appropriate statement in each of the 5 dimensions. From these 5 dimensions an EuroQoL-5 Dimension Youth (EQ5DY) value is calculated. This measure also includes a Visual Analogue Scale on how good or bad the participant's health is "today", on a vertical scale of 0 to 100. The endpoints of the scale are labelled "100 The best health you can imagine" and "0 The worst health you can imagine." This will be rated by the child (the participant) and their parent/legal guardian (using a proxy version).

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

  5. Child Health Utility 9D (CHU9D)

    The Child Health Utility 9D (CHU9D) is a paediatric self-reported generic quality of life measure. It consists of nine dimensions; "worried", "sad", "pain", "tiredness" "annoyed", "school work/homework", "sleep", "daily routine" and "able to join in activities". The measure is rated on a five point scale on which the participants rate the level to how they are feeling, with a "don't" sentence linked with no problems (e.g. I don't feel sad today) and "very" with the participant experiencing a lot of problems (e.g. I feel very sad). Calculation of an universal score is supported by a specific scoring algorithm, with 1 representing 'full health' and 0 'death'. In this study the CHU9D is rated by the child (the participant) and their parent/legal guardian (using a proxy version).

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

  6. Foot pain score measured by numeric rating scale

    Self-report pain status will be measured using a Numeric Rating Scale (NRS) of 0 to 9. The participant will be asked to estimate their pain intensity over the past week, where 0 indicates no pain at all and 9 the worst pain. In this study the foot pain score with numeric rating is rated by the participant's parent/legal guardian .

    Time frame: Collected once a week for 12 weeks and at baseline, 3, 6 and 12 months post randomisation

  7. Healthcare resource use

    Self report healthcare resource use. Healthcare utilisation will be recorded in primary care and the community and within the hospital setting.

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

  8. Foot pain over past week measured by Wong-Baker Faces pain rating scale

    Self-report measure of pain in left and right feet, using Wong-Baker faces pain rating scale (0-10) where 0 indicates no pain at all and 10 being the worst possible pain. In this study the foot pain score is rated by the child (the participant).

    Time frame: Collected at baseline, 3,6 and 12 months post randomisation

Other outcomes

  1. Proportion of participants who go on to be randomised to the OSTRICH trial.

    Primary outcome for the 'pen and signposting to multimedia trial information Study within a Trial

    Time frame: Post randomisation

  2. Retention to main OSTRICH trial

    Secondary outcome for the 'pen and signposting to multimedia trial information Study within a trial

    Time frame: 3, 6 and 12 months post randomisation

  3. Response rate to the participant follow-up questionnaire at the first time point following receipt of the birthday card

    Primary outcome to 'birthday card' Study within a Trial

    Time frame: Next followup either , 3, 6 or 12 months post randomisation

  4. Response rate to the participant follow-up paper questionnaire at the 12-month follow-up

    Secondary outcome to 'birthday card' Study within a Trial

    Time frame: 12 months post randomisation

  5. Completeness of host-trial primary outcome measure

    Secondary outcome to 'birthday card' Study within a Trial

    Time frame: 12 months post randomisation

  6. Time to return postal questionnaire

    Secondary outcome to 'birthday card' Study within a Trial

    Time frame: 3, 6 and 12 months post randomisation

  7. Need for questionnaire reminder

    Secondary outcome to 'birthday card' Study within a Trial

    Time frame: 3, 6 and 12 months post randomisation

  8. Qualitative interviews

    Parental/legal guardian and child experiences and management of pes planus

    Time frame: Interviews will be conducted throughout the study

  9. 3D foot scan

    3D scan of both feet

    Time frame: Baseline and at 12 months

07

Study locations

16 sites
  • East Cheshire NHS Trust
    Macclesfield, Cheshire SK10 3BL, United Kingdom
  • Birmingham Community Healthcare NHS Foundation Trust
    Birmingham, B7 4BN, United Kingdom
  • Bolton NHS Foundation Trust
    Bolton, BL4 OJR, United Kingdom
  • Cardiff and Vale University Local Health Board
    Cardiff, CF14 4XW, United Kingdom
  • Medway Community Healthcare
    Gillingham, ME8 0PZ, United Kingdom
  • North Lincolnshire & Goole NHS Foundation Trust
    Goole, United Kingdom
  • Harrogate and District Foundation Trust
    Harrogate, HG2 7SX, United Kingdom
  • Leeds Community Healthcare NHS Trust
    Leeds, LS6 1PF, United Kingdom
  • Leeds Teaching Hospitals NHS Trust
    Leeds, LS9 7TF, United Kingdom
  • Kent Community Health NHS Foundation Trust
    Maidstone, ME16 9NT, United Kingdom
  • South Tees Hospitals NHS Foundation Trust
    Middlesbrough, TS4 3BW, United Kingdom
  • Lancashire & South Cumbria Nhs Foundation Trust
    Preston, PR5 6AW, United Kingdom
  • University Hospital Southampton NHS Foundation Trust
    Southampton, SO16 6YD, United Kingdom
  • Solent NHS Trust
    Southampton, United Kingdom
  • Royal National Orthopaedic Hospital NHS Trust
    Stanmore, HA7 4LP, United Kingdom
  • Walsall Healthcare NHS Trust
    Walsall, United Kingdom
08

References and documents

Publications

  • Evans AM, Rome K, Carroll M, Hawke F. Foot orthoses for treating paediatric flat feet. Cochrane Database Syst Rev. 2022 Jan 26;1(1):CD006311. doi: 10.1002/14651858.CD006311.pub4. PubMed 35080267 ↗
  • Evans AM, Rome K, Carroll M, Hawke F. Foot orthoses for treating paediatric flat feet. Cochrane Database Syst Rev. 2022 Jan 14;1(1):CD006311. doi: 10.1002/14651858.CD006311.pub3. PubMed 35029841 ↗

Individual participant data

Plan to share: No — Requests for OSTRICH study data may be submitted to the Chief Investigator once the results of the study have been published. Requests will be dealt with on a case by case basis and in accordance with the University of York, Department of Health Sciences, York Trials Unit's Standard Operating Procedures.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04104555
Lead sponsor
University of York
Collaborators
University of Leeds, University of Salford, University of Oxford, King's College London, University of Warwick
Responsible party
Sarah Cockayne (Research Fellow, University of York) — Principal investigator
First posted
Sep 26, 2019
Start date
Apr 21, 2022
Primary completion
Aug 31, 2023
Completion
Aug 31, 2023
Last update
Nov 29, 2023

Study contacts

David Torgerson, PhD
principal investigator · University of York

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion